A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
Clinical trial NCT05593029 · COMPLETED
Trial details
- NCT number
- NCT05593029
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-09
- Primary completion
- 2025-11-06
- Enrollment
- 929
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.